Insider Transactions in Q2 2021 at T Rx Ade Health, Inc (MEDS)
Insider Transaction List (Q2 2021)
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Jun 21
2021
|
Michael L Peterson Director |
SELL
Open market or private sale
|
Direct |
900
-14.32%
|
$3,600
$4.45 P/Share
|
May 27
2021
|
Christine L. Jennings Director |
BUY
Grant, award, or other acquisition
|
Direct |
10,912
+50.0%
|
$32,736
$3.78 P/Share
|
May 27
2021
|
Michael L Peterson Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
8,041
-56.12%
|
-
|
May 27
2021
|
Pamela Tenaerts |
SELL
Sale (or disposition) back to the issuer
|
Direct |
8,041
-42.53%
|
-
|
May 27
2021
|
Charles L Pope Director |
BUY
Grant, award, or other acquisition
|
Direct |
10,912
+50.0%
|
$32,736
$3.78 P/Share
|
May 05
2021
|
Donald G. Fell Director |
SELL
Bona fide gift
|
Direct |
300
-1.67%
|
-
|
May 04
2021
|
Donald G. Fell Director |
SELL
Bona fide gift
|
Direct |
2,250
-11.14%
|
-
|
Apr 19
2021
|
Donald G. Fell Director |
BUY
Grant, award, or other acquisition
|
Direct |
10,721
+34.68%
|
$53,605
$5.13 P/Share
|
Apr 19
2021
|
Michael L Peterson Director |
BUY
Grant, award, or other acquisition
|
Direct |
10,721
+38.66%
|
$53,605
$5.13 P/Share
|
Apr 19
2021
|
Michael L Peterson Director |
SELL
Open market or private sale
|
Direct |
900
-12.52%
|
$3,600
$4.68 P/Share
|
Apr 19
2021
|
Pamela Tenaerts |
BUY
Grant, award, or other acquisition
|
Direct |
10,721
+36.18%
|
$53,605
$5.13 P/Share
|
Apr 19
2021
|
Prashant Patel Interim CFO and Director |
SELL
Open market or private sale
|
Direct |
7,500
-0.6%
|
$30,000
$4.39 P/Share
|